Antibacterial prophylaxis in neutropenic patients

Claudio Viscoli

Research output: Contribution to journalArticlepeer-review


Antibiotic prophylaxis has been used for several decades to prevent infection in chemotherapy-induced neutropenia and its benefits have been debated just as long. Recent analysis suggests that quinolones may actually be life saving in high-risk groups such as acute leukaemia and autologous bone marrow transplant but these benefits are likely to be negated in the long term by the development of quinolone resistance.

Original languageEnglish
Pages (from-to)60-65
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Issue numberSUPPL. 1
Publication statusPublished - Nov 2007


  • Antibacterial prophylaxis
  • Cancer
  • Leukaemia
  • Quinolones

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Antibacterial prophylaxis in neutropenic patients'. Together they form a unique fingerprint.

Cite this